Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Peripheral blood minimal/measurable residual disease assessed in flow cytometry in acute myeloblastic leukemia
Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study
